1E Therapeutics (1Etx) is a breakthrough, clinical stage drug development company creating first-in-class RNA-targeting therapeutics based on our proprietary drug design platform.
1E is the culmination of years of innovation, effort, and tens of millions of $US investment in research and development.
1E's proprietary and groundbreaking rapid drug design process has proven uniquely able to
develop innovative drugs that address chronic life threatening indications as well as emerging and evolving pathogens
1E already has lead compounds that address a wide array of indications
in oncology and age-related diseases, immunology, anti-microbial resistance, viral infections, and orphan neurological disorders.
1E’s most advanced lead is already in a Phase 1/2 clinical trial, and the company is positioned to have multiple programs in the clinic within the next 2 years
We are looking for spirited researchers who will be highly engaged in the company mission to develop novel therapeutics for major unmet medical needs.The researcher will join an R&D team developing the company’s core technology
We are looking for technology-oriented people having vast knowledge in RNA biology, and related methodologies.
The position includes a significant component of “wet” bench-work. Candidates are expected to be excellent team players